Evidence and decision-making in times of pandemic

  • Iván D. Flórez a. Department of Pediatrics and Child Care, Universidad de Antioquia. Medellín, Colombia. b. Department of Health Research Methods, Evidence and Impact, McMaster University. Hamilton, Canada. https://orcid.org/0000-0002-0751-8932
  • Javier M. Sierra Department of Pediatrics and Child Care, Universidad de Antioquia. Medellín, Colombia. https://orcid.org/0000-0002-4131-0801
  • José Andrés Calvache a. Department of Anesthesiology, Universidad del Cauca. Popayán, Colombia. b. Department of Anesthesiology, Erasmus University Medical Center Rotterdam, The Netherlands. c. Editor-in-Chief Colombian Journal of Anesthesiology. Bogotá, Colombia. http://orcid.org/0000-0001-9421-3717
Keywords: Evidence, Decision-making, Pandemic, COVID-19

References

Sayare S. He was a science star. Then he promoted a questionable cure for Covid-19. The New York Times Magazine [internet]. 2020 [citado: 2020 jul. 29]. Disponible en: https://www.nytimes.com/2020/05/12/magazine/didier-raoult-hydroxychloroquine.html

Sammuels E, Kelly M. How false hope spread about hydroxychloroquine to treat covid-19 — and the consequences that followed. The Washington Post [internet]. 2020 [citado: 2020 jul. 29]. Disponible en: https://www.washingtonpost.com/politics/2020/04/13/how-false-hope-spread-about-hydroxychloroquine-its-consequences/

Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azitromicin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1):105949. doi: https://doi.org/10.1016/j.ijantimicag.2020.105949

Machiels JD, Bleeker-Rovers CP, Heine R, et al. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks? Int J Antimicrob Agents. 2020;56(1):106056. doi: https://doi.org/10.1016/j.ijantimicag.2020.106056

Evans I, Thornton H, Chalmers I, et al. Testing treatments: Better research for better healthcare. 2nd edition. Londres: Pinter & Martin; 2011.

Lipsitch M. Good science is good science: we need specialists, not sects. Eur J Epidemiol. 2020;35(6):519-22. doi: https://doi.org/10.1007/s10654-020-00651-2

Djulbegovic B, Guyatt G. EBM and the theory of knowledge. En: Guyatt G, Meade M, Cook D, eds. Users' guides to the medical literature: A manual for evidence-based clinical practice. Boston: McGraw-Hill; 2014.

Rutter H, Wolpert M, Greenhalgh T. Managing uncertainty in the covid-19 era. https://blogs.bmj.com/bmj/2020/07/22/managing-uncertainty-in-the-covid-19-era/

Djulbegovic B, Guyatt G. Evidence-based medicine in times of crisis. J Clin Epidemiol. 2020. doi: https://doi.org/10.1016/j.jclinepi.2020.07.002

Kalil AC. Treating COVID-19-off-label drug use, compassionate use, and randomized clinical trials during pandemics. JAMA. 2020;323(19):1897-8. doi: https://doi.org/10.1001/jama.2020.4742

RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with covid-19 — preliminary report. New Eng J Med. 2020. doi: https://doi.org/10.1056/NEJMoa2021436

Siemieniuk Reed AC, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Pardo-Hernández H, et al. Drug treatments for covid-19: living systematic review and network meta-analysis BMJ. 2020;370:m2980. doi: https://doi.org/10.1136/bmj.m2980

How to Cite
1.
Flórez ID, Sierra JM, Calvache JA. Evidence and decision-making in times of pandemic. Colomb. j. anesthesiol. [Internet]. 2020Sep.7 [cited 2020Sep.26];48(4). Available from: https://www.revcolanest.com.co/index.php/rca/article/view/931

Downloads

Download data is not yet available.
Published
2020-09-07
How to Cite
1.
Flórez ID, Sierra JM, Calvache JA. Evidence and decision-making in times of pandemic. Colomb. j. anesthesiol. [Internet]. 2020Sep.7 [cited 2020Sep.26];48(4). Available from: https://www.revcolanest.com.co/index.php/rca/article/view/931
Section
Editorial